Threshold Crossing by Baillie Gifford at Nanobiotix

On November 22, 2024, Nanobiotix announced a threshold crossing by Baillie Gifford & Co. This company reduced its stake in Nanobiotix below 5% of the capital. Baillie Gifford & Co., manager on behalf of its clients and funds, now holds 2,364,538 shares. This represents 4.99% of the capital and 4.81% of the voting rights of the company.

This change is the result of a sale of shares on the market. Previously, Baillie Gifford & Co. had crossed the 5% reporting threshold, as stipulated by Article L. 233-7 of the French Commercial Code.